This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
For more information, please view the literature below.
Serum (preferred) or plasma
1 mL (adult), 0.8 mL (pediatric)
0.7 mL (adult), 0.3 mL (pediatric) (Note: This volume does not allow for repeat testing.)
Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma.
If a red-top tube or plasma is used, transfer separated serum or plasma to a plastic transport tube.
Thyroid function test. Decreased in hypothyroidism and in the third stage of (painful) subacute thyroiditis; increased with hyperthyroidism, with subacute thyroiditis in its first stage and with thyrotoxicosis due to Hashimoto disease.3 Used to diagnose T4 toxicosis.
T4 may be increased with excess intake of iodine or with surreptitious use of thyroxine.3 T4 levels may be abnormal in the presence of systemic nonthyroidal disease. Alterations in binding capacity or quantity of TBG may increase or decrease total thyroxine without causing symptoms. A common cause of elevated T4 in nonthyroidal disease is said to be liver disease. Serum thyroxine and free thyroxine index (FTI) are increased in familial dysalbuminemic hyperthyroxinemia, a euthyroid syndrome in which an abnormal binding site has affinity for thyroxine.4 The T3 is usually normal in this entity, as is T3 uptake (THBR). Thus, T3 uptake is commonly ordered with T4.
Electrochemiluminescence Immunoassay (ECLIA)
The combination of the serum T4 and T3 uptake (THBR) as an indirect assessment of TBG, helps to determine whether an abnormal T4 value is due to alterations in serum thyroxine-binding globulin or to changes of thyroid hormone levels. Deviations of both tests in the same direction usually indicate that an abnormal T4 is due to abnormalities in thyroid hormone. Deviations of the two tests in opposite directions provide evidence that an abnormal T4 may relate to alterations in TBG.
Causes of increased TBG binding include neonatal state, molar and conventional pregnancy, estrogens, oral contraceptives, heroin, methadone, 5-fluorouracil, clofibrate, infectious hepatitis, chronic active hepatitis, and primary biliary cirrhosis, acute intermittent porphyria, lymphoma, and hereditary TBG increase.
Amphetamines, iopanoic acid, ipodate, and amiodarone increase thyroxine.5,6 High dose propranolol may elevate T4 and FTI levels.7
Causes of decreased TBG binding include abnormal protein states especially nephrotic syndrome, androgens, anabolic steroids, prednisone, acromegaly, liver or other systemic illness, severe stress or hereditary TBG deficiency. Salicylates and diphenylhydantoin may lower T4 significantly. Amiodarone may cause increased thyroxine levels and can cause hypothyroidism or hyperthyroidism.
Lithium carbonate may cause goiter with or without hypothyroidism.
Carbamazepine (Tegretol®) is reported to cause decreased values in thyroid function tests.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|001149||Thyroxine (T4)||3026-2||001149||Thyroxine (T4)||ug/dL||3026-2|
|Reflex Table for Thyroxine (T4)|
|Order Code||Order Name||Result Code||Result Name||UofM||Result LOINC|
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf